Search Results

On World Alzheimer’s Day and every day, we work hard to care for Veterans living with Alzheimer’s disease. Learn more about careers where you can make a difference.

Dr. Mark Logue details his research connecting PTSD and TBI with Alzheimer’s and dementia genetic risk in Veterans.

Importantly, the investigators went on to identify two FDA-approved medications that could obstruct the dangerous process. They say these drugs could suggest new directions in TBI and Alzheimer’s research and treatment.

This scanning method could become a simple, completely non-invasive method of early Alzheimer’s detection, according to the researchers, and also has potential as a way to assess the effectiveness of treatment.

Alzheimer’s disease is the most common form of dementia. Dementia can affect memory and actions. Two-thirds of Americans with Alzheimer’s disease are women. And they are more than 60% of caregivers.

Research has linked head injury and a variety of mental health conditions to a higher risk of Alzheimer’s and dementia. About 50 percent of our Veterans age 65 or older face an even greater risk.

San Francisco VA offers new Alzheimer’s treatment to slow symptoms in Veterans. Innovative therapy provides hope and early intervention.

This week, VA's Office of Research and Development published three News Briefs highlighting research advances for Veterans in caregiver training, Alzheimer's disease and toxic exposure.

VA Boston Brain Bank provides central nervous system tissue to scientists studying Veteran disorders of Gulf War and PTSD.

As a result of her grandmother's death from Alzheimer’s disease, a would-be fourth generation farmer embarked on a different career path.

Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s in the U.S. One million Americans live with Parkinson’s today — and of those approximately 110,000 Veterans with PD receive Parkinson’s treatment through VA.

Preventing or treating Alzheimer’s a priority for VA research. One recent study focused on apathy, a common behavioral problem in those with Alzheimer’s. Doctor enthusiastic about therapy’s potential.